RESEARCH ARTICLE


https://doi.org/10.5005/jp-journals-10016-1172
International Journal of Infertility and Fetal Medicine
Volume 9 | Issue 3 | Year 2018

Impact of Weight Loss on Reproductive Hormones in Obese Men


Mir Jaffar1, Syed Waseem Andrabi2, SML Prakash Babu3, SA Subramani4

1Department of Andrology, Milann Hospital, Bengaluru, Karnataka, India
2Department of Zoology, University of Lucknow, India
3Department of Urology, MS Ramiah Medical College, Bengaluru, Karnataka, India
4Department of Plastic Surgery, Vydehi Institute of Medical Sciences and Research Center, Bengaluru, Karnataka, India

Corresponding Author: Mir Jaffar, Department of Andrology, Milann Hospital, Bengaluru, Karnataka, India, Phone: +91 9886702931, e-mail: mir.jaffar@gmail.com

How to cite this article: Jaffar M, Andrabi SW, et al. Impact of Weight Loss on Reproductive Hormones in Obese Men. Int J Infertil Fetal Med 2018;9(3):32–36.

Source of support: Nil

Conflict of interest: None

ABSTRACT

Objective: To determine whether weight loss in obese men improves reproductive hormones.

Design: Prospective interventional study.

Setting: Infertility clinic and weight loss centers.

Patients: All obese men attending infertility center from April 2012 to May 2015 (n = 105).

Intervention(s): Diet counseling and exercise.

Materials and methods: Obese men aged 25–40 years (mean age = 32.5 ± 7.5) with BMI more than 25 kg/m2 were recruited for the study. The subjects underwent a weight loss intervention and were followed up for 1-year post intervention. Their semen parameters were checked before and after weight loss.

Main outcome measures: Collected reproductive parameters included testosterone (T), sex hormone-binding globulin (SHBG), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) serum hormonal values. A paired t test was done to evaluate differences across the before and after groups. Chi-square/Fisher exact test was used to find the significance of study parameters on a categorical scale between two or more groups.

Results: The mean BMI was significantly higher before weight loss (33.2) than after weight loss (30.4) in obese men. The weight loss increased the T to 35.40 ± 20.51 ng/mL compared with 27.16 ± 20.71 ng/mL, and SHBG to 23.72 ± 9.01 µg/dL compared with 19.18 ± 10.44 µg/dL, whereas FSH and LH were nonsignificant.

Conclusion: The study showed that a high BMI at the baseline was associated with low values of serum T and SHBG. FSH and LH were considerably low in morbidly obese men before weight loss. Weight loss was associated with an increase in serum T and SHBG. FSH and LH were not statistically significant after weight loss except in morbidly obese men who showed clear aromatization influence. The hormonal profile among obese men evaluated in this study was characterized by abnormalities in the sex hormones, and weight loss improved some of the hormone levels; however, they were not normalized.

Keywords: Body mass index, Male infertility, Male reproductive hormones, Obesity, Weight loss.

INTRODUCTION

Infertility is defined as the inability to conceive after 1 year of unprotected intercourse. Most of the developed countries are bearing the brunt of high frequency of overweight or obesity.1 In the developing world, the prevalence of overweight and obesity is increasing at alarming rates,26 and, in some countries, has reached levels observed in the developed world.7,8 Although overweight and obesity have been demonstrated to affect female fertility,9 there is no consensus on the effects on male fertility and seminal para-meters.1012 Epidemiologic studies performed at the population level and in infertile couples during recent years suggest that obesity is associated with reduced male fertility, although this effect seems to be modest.13 Male obesity has been linked to subfecundity and an effect–response relationship between increasing BMI and subfecundity has been proposed.1416 A higher prevalence of obesity in developing countries is associated with the change from rural to urban lifestyle causing decreased levels of physical activity and an increased intake of energy-dense diet. In addition to lifestyle changes, genetics also play a role in increasing obesity in India. India and most of the Asia-Pacific population have a mutation of MC4R genes which put them into the high-risk population.17 WHO has reclassified the obesity limits for Asians/Indians as indicated in Table 1.18

Male obesity has been associated with abnormal semen characteristics,1926 although results are conflicting.2733 Obesity has shown to affect the gonadotropin releasing hormone–luteinizing hormone/follicle stimulating hormone (GnRH–LH/FSH) pulse that may impair Leydig and Sertoli cell functions and with the release of sex hormones with a consequent effect on sperm maturation.34 This altered reproductive hormonal profile suggests that the endocrine dysregulation in obese men could explain the increased risk of altered semen parameters.

Table 1: WHO recommended classification for Indian population
BMI cut off values for adults
Asians/Indians 2000
  Underweight<18.5<18.5
  Normal range18.5–24.918.5–22.9
  Overweight (pre-obese)25.0–29.923.0–24.9
  Obese class I30.0–34.925.0–29.9
  Obese class II35.0–39.9≥30.0
  Obese class III≥40.0

WHO. Obesity: Preventing and Managing the Global Epidemic, 2000 (TRS 894)

WHO/IOTF/IASO (2000). The Asia-Pacific perspective: redefining Obesity and its treatment

Obesity and nutritional habits are mainly associated with significant changes in the plasma hormonal milieu, such as a decrease in total and free testosterone levels, decreased gonadotropin levels, decreased the binding capacity of sex hormone-binding globulin, and hyperestrogenemia.3538 All these alterations might affect the male reproductive system and gamete quality. Previous studies have shown that the endocrine abnormalities may be reversed by weight reduction.3944 This study aimed to review the changes in semen parameters before and after weight loss in obese males.

MATERIALS AND METHODS

Obese men aged 25–40 years (mean age = 32.5 ± 7.5) with BMI more than 25 kg/m2 were recruited for the study. The subjects underwent a weight loss intervention and were followed up for 1-year postintervention.

We excluded two men diagnosed with Klinefelter’s syndrome, and in the analyses of semen characteristics, two with retractile testis and seven men with azoospermia were excluded because azoospermia probably is not caused by obesity alone. The weight loss intervention, based on a healthy diet and daily exercise, lasted approximately 12 weeks. The participants completed questionnaires on their reproductive experience, medical, and lifestyle factors before and after the intervention. Testicular volume was measured by Prader-Orchidometer at baseline by a trained person. The clinical examination was performed on the site by one investigator and included blood pressure by mercurial sphygmomanometer, blood sugar level (Accu-check), height, and weight measurements (Table 2).

The participants were asked to provide the semen sample by masturbating into a plastic container after at least 48 hours of sexual abstinence. Those who preferred semen collection at home were instructed to keep the container close to the body, during transportation to the laboratory to avoid cooling, and the same person during the whole course performed all initial semen analyses within 1 hour after collection. The men received no incentives, and participation was conditional on written informed consent. The regional ethics committee approved the study (P-RM-08/2012).

Table 2: Characteristics of study participants
ParameterBefore interventionAfter intervention% change
BMI <18.5 (kg/m2)0 (0%)0 (0%)0.0%
BMI 18.5–24.9 (kg/m2)0 (0%)11 (10.5%)10.5%
BMI 25.0–29.9 (kg/m2)25 (23.8%)47 (44.8%)21.0%
BMI 30.0–34.9 (kg/m2)57 (54.3%)31 (29.5%)−24.8%
BMI 35.0–39.9 (kg/m2)12(11.4%)7(6.7%)−4.7%
BMI ≥40.0 (kg/m2)11 (10.5%)9 (8.6%)−1.9%
Smoking34 (32.4%)34 (32.4%)0.0%
Alcohol consumption21 (20%)14 (13.3%)−6.7%
Hypertension10 (9.5%)11 (10.5%)1.0%
Diabetes7 (6.7%)7 (6.7%)0.0%

Analyses of Semen Samples

The semen volume was estimated by 3 mL Pasteur pipette (Tarsons). Sperm concentration and motility were assessed as described in the “WHO Laboratory Manual” (World Health Organization, 2010). Analysis of the samples was initiated within 1 hour after ejaculation, and, within this time, it has been shown that the sperm motility is stable.45 All the samples were analyzed by using the CASA system (CASA, NIKON Model Eclipse E200) for count and motility supported by the Mackler chamber.

Men with azoospermia and severe oligospermia (<5 × 106) were ruled out for Y-chromosome microdeletions. Then they were subjected to a weight reduction program, which includes diet counseling, exercise, or/and lipolysis for a duration of minimum 3 months. On follow-up after 3 months of post weight loss, screening was repeated for the participants. All the previous tests were repeated once again and the results were compared with their previous results and the difference studied.

Statistical Methods

Descriptive and inferential statistical analysis has been carried out in the present study.4649 Results on continuous measurements are presented as mean ± SD and results on categorical measurements are presented in number (%). A p value of <0.05 was regarded as significant. A paired t test was done to evaluate differences across the before and after groups. The Chi-square/Fisher exact test has been used to find the significance of study parameters on a categorical scale between two or more groups.

Statistical Software

The Statistical software namely SAS 9.2, SPSS 15.0, Stata 10.1, MedCalc 9.0.1, Systat 12.0, and R environment ver.2.11.1 were used for the analysis of the data and Microsoft Word and Excel have been used to generate graphs, tables, etc.

RESULTS

Data were prospectively collected between April 2012 and May 2015. A total of 213 men were invited to participate, of which 126 men (57%) were recruited. Out of the 126 participants, 21 were excluded according to our exclusion criteria (16%), and the remaining 105 were actually recruited for our weight loss program.

Table 3: Assessment of study variables before and after intervention
VariablesBefore interventionAfter interventionDifferencet valuep-value
BMI (kg/m2)33.18 ± 5.0630.43 ± 5.982.75510.257<0.001**
Vol in mL  2.44 ± 0.802.52 ± 0.67−0.085−1.751 0.083+
Count/mL36.38 ± 27.0537.43 ± 23.46−1.051−0.8140.418
PR%29.35 ± 21.9141.06 ± 24.40−11.712−4.282<0.001**
NP%17.57 ± 9.7118.70 ± 9.49−1.130−0.9170.361
Static%53.70 ± 24.2739.97 ± 22.5013.7375.386<0.001**

Student t test (paired)

+ Suggestive significance (p-value: 0.05 < p < 0.10)

* Moderately significant (p-value: 0.01< p ≤ 0.05)

** Strongly significant (p-value: p ≤ 0.01)

Figs 1A to F: Impact of weight loss on different seminal parameters; (A) BMI; (B) Volume; (C) Count; (D) Progressive; (E) Nonprogressive; (F) Static

The data of the studied groups are represented in Table 3 and Figure 1. The mean BMI was significantly higher in group I (before weight loss) than in group II (after weight loss) obese men. Weight loss had a significant positive correlation with the percentage of progressive motile sperm and the percentage of static sperm. Weight loss had a suggestive significant correlation with semen volume and nonsignificant correlation with concentration and nonprogressive motile sperm (Table 3 and Fig. 1).

STUDY DESIGN

A prospective interventional study.

DISCUSSION

Limited studies have evaluated the effects of weight loss with diet and exercise and its impact on male fertility. Most of the studies have been conducted in a hospital set-up where the chances of infertile obese couples visiting and taking part in research studies are high creating a bias. This study evaluates the effects of obesity and weight-loss interventions in male fertility in the general population.

Our study showed that a high BMI at the baseline was associated with low values of total sperm count, sperm concentration, and motile sperm count. We did not observe statistically significant differences in sperm concentration, volume, or nonprogressive sperm count. Weight loss was associated with an increase in the percentage of progressive motile sperm and a decrease in static sperm percentage among men who participated in a 12-week weight loss program. Our results indicate that there is a causal inverse association between BMI and semen quality, suggesting that it may be possible to improve semen quality by weight reduction. Previous studies have reported a higher prevalence of oligospermia in overweight and obese men than in normal-weight men with a significant association between sperm count and BMI.50

Studies comparing obese and normal normozoospermic men have reported lower sperm counts in the former group.51 BMI has been established to have a negative correlation with a total number of normal spermatozoa.52 Obesity has been implicated to have direct and indirect impacts that could reduce male fertility including decreased sperm motility and increased DNA fragmentation.53,54 Weight reduction among men with obstructive sleep apnea secondary to obesity increased testosterone levels.55 Physical inactivity negatively impacts on erectile function, and exercise interventions have been shown to improve sexual responses. A reduction in caloric intake has also been found to improve erectile function in men with aspects of the metabolic syndrome, including obesity and diabetes.56

Hormonal alterations and diminished sexual quality of life have both been reported to improve after gastric bypass surgery.57 Even though natural weight loss and even gastric bypass have shown promising results in terms of restoring fertility and surgical treatment has been shown to restore reproductive hormones to normal levels, some studies indicate that gastric bypass procedure and the drastic weight loss might induce secondary infertility. One report has described six previously fertile men who lost 60–80 kg after a Roux-en-Y gastric bypass but developed secondary infertility and complete azoospermia ultimately attributed to complete spermatogenic arrest.58

The BMI is a measure of weight in relation to height and does not directly reflect the percentage of body fat. Some of the men with a high BMI may in fact not be obese but have a large muscle mass, which may not be associated with reduced semen quality. Differences in the distribution of confounders such as period of abstinence, smoking, alcohol, diabetes mellitus, and hypertension may influence our finding. We did, however, take into account these factors in the regression analyses and they are unlikely to explain our findings

It should be noted that a few men in spite of losing weight remained overweight/obese after the weight loss program.

CONCLUSION

To conclude on this study, we observed that the altered androgen profile tend to improve following weight loss and that weight loss may potentially lead to an improvement in semen quality, although we cannot conclude this to be a result of the reduction in body weight per se.

Though a lot of research still need to be carried out to clear the gray area to set up concrete mechanisms involved in the obesity and develop an effective treatment protocol for obese infertile men. However, the available clinical evidence is strong enough for health policies to be implemented immediately in public and private settings regarding preconception counseling and different approaches of treatment for the obese population without further delay. The promotion of weight excess prevention and control, especially through lifestyle therapies, should be mandatory not only for improving reproductive and obstructive outcomes but also for reducing the cost of medical treatment eradicating or treating the secondary diseases with the obesity as the root cause.

ACKNOWLEDGMENT

For sample size estimation and complete data analysis, the authors wish to thank Dr KP Suresh, Scientist (Biostatistics), National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Bengaluru 560024.

References

1. Ogden CL, Carroll MD, et al. Prevalence of overweight and obesity in the United States,1999–2004. JAMA 2006;295:1549–1555. DOI: 10.1001/jama.295.13.1549.

2. Tuan NT, Tuong PD, et al. Body mass index (BMI) dynamics in Vietnam. Eur J Clin Nutr 2008;62:78–86. DOI: 10.1038/sj.ejcn.1602675.

3. Dearth-Wesley T, Wang H, et al. Under- and overnutrition dynamics in Chinese children and adults (1991–2004). Eur J Clin Nutr 2007 July 18;62:1302–1307. DOI: 10.1038/sj.ejcn.1602853.

4. Uauy R, Albala C, et al. Obesity trends in Latin America: transiting from under to overweight. J Nutr 2001;131:893S–899S. DOI: 10.1093/jn/131.3.893S.

5. Villamor E, Msamanga G, et al. Trends in obesity, underweight and wasting among women attending prenatal clinics in urban Tanzania: 1995–2004. Am J Clin Nutr 2006;83:1387–1394. DOI: 10.1093/ajcn/83.6.1387.

6. Rivera J, Baquera S, et al. Nutrition transition in Mexico and other Latin American countries. Nutr Rev 2004;62:S148–S157. DOI: 10.1301/nr.2004.jul.S149-S157.

7. Filozof C, Gonzalez C, et al. Obesity prevalence and trends in Latin-American countries. Obes Rev 2001;2:99–106. DOI: 10.1046/j.1467-789x.2001.00029.x.

8. WHO Consultation on Obesity (1999: Geneva). Obesity: preventing and managing the global epidemic: report of a WHO consultation. Geneva: World Health Organization; 2000.

9. Fedorcsak P, Dale PO, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004;19:2523–2528. DOI: 10.1093/humrep/deh485.

10. Strain GW, Zumoff B, et al. Mild hypogonadotropic hypogo-nadism in obese men. Metabolism 1982;31:871–875. DOI: 10.1016/0026-0495(82)90175-5.

11. Pauli EM, Legro RS, et al. Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril 2008;90:346–351. DOI: 10.1016/j.fertnstert.2007.06.046.

12. Hammoud AO, Wilde N, et al. Male obesity and alteration in sperm parameters. Fertil Steril 2008;90:2222–2225. DOI: 10.1016/j.fertnstert.2007.10.011.

13. Hammoud AO, Gibson M, et al. Impact of male obesity on infertility: a critical review of the current literature. Fertil Steril 2008;90:897–904. DOI: 10.1016/j.fertnstert.2008.08.026.

14. Sallmen M, Sandler DP, et al. Reduced fertility among overweight and obese men. Epidemiology 2006;17:520–523. DOI: 10.1097/01.ede.0000229953.76862.e5.

15. Ramlau Hansen CH, Thulstrup AM, et al. Subfecundity in overweight and obese couples. Hum Reprod 2007;22:1634–1637. DOI: 10.1093/humrep/dem035.

16. Nguyen RH, Wilcox AJ, et al. Men’s body mass index and infertility. Hum Reprod 2007;22:2488–2493. DOI: 10.1093/humrep/dem139.

17. Lee YS. Melanocortin 3 receptor gene and melanocortin 4 receptor gene mutation: the Asian Perspective. Diabetes Metab Res Rev 2012;28:26–31. DOI: 10.1002/dmrr.2351.

18. WHO/IOTF/IASO (2000).The Asia-Pacific perspective: Redefining Obesity and its Treatment.

19. Jensen TK, Andersson AM, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004;82:863–870. DOI: 10.1016/j.fertnstert.2004.03.056.

20. Magnusdottir EV, Thorsteinsson T, et al. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod 2005;20:208–215. DOI: 10.1093/humrep/deh569.

21. Koloszar S, Fejes I, et al. Effect of body weight on sperm concentration in normozoospermic males. Arch Androl 2005;51:299–304. DOI: 10.1080/01485010590919701.

22. Fejes I, Koloszar S, et al. Effect of body weight on testosterone/estradiol ratio in oligozoospermic patients. Arch Androl 2006;52:97–102. DOI: 10.1080/01485010500315479.

23. Kort HI, Massey JB, et al. Impact of body mass index values on sperm quantity and quality. J Androl 2006;27:450–452. DOI: 10.2164/jandrol.05124.

24. Stewart TM, Liu DY, et al. Associations between andrological measures, hormones and semen quality in fertile Australian men: inverse relationship between obesity and sperm output. Hum Reprod 2009;24:1561–1568. DOI: 10.1093/humrep/dep075.

25. Chavarro JE, Toth TL, et al. Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic. Fertil Steril 2010;93:2222–2231. DOI: 10.1016/j.fertnstert.2009.01.100.

26. Hofny ERM, Ali ME, et al. Semen parameters and hormonal profile in obese fertile and infertile males. Fertil Steril 2010;94:581–584. DOI: 10.1016/j.fertnstert.2009.03.085.

27. Qin DD, Yuan W, et al. Do reproductive hormones explain the association between body mass index and semen quality? Asian J Androl 2007;9:827–834. DOI: 10.1111/j.1745-7262.2007.00268.x.

28. Aggerholm AS, Thulstrup AM, et al. Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile? Fertil Steril 2008;90:619–626. DOI: 10.1016/j.fertnstert.2007.07.1292.

29. Pauli EM, Legro RS, et al. Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril 2008;90:346–351. DOI: 10.1016/j.fertnstert.2007.06.046.

30. Ramlau Hansen CH, Hansen M, et al. Semen quality and reproductive hormones according to birthweight and body mass index in childhood and adult life: two decades of follow-up. Fertil Steril 2010;94:610–618. DOI: 10.1016/j.fertnstert.2009.01.142.

31. Wise LA, Rothman KJ, et al. An internet based prospective study of body size and time to pregnancy. Hum Reprod 2010;25:253–264. DOI: 10.1093/humrep/dep360.

32. Martini AC, Tissera A, et al. Overweight and seminal quality: a study of 794 patients. Fertil Steril 2010;94:1739–1743. DOI: 10.1016/j.fertnstert.2009.11.017.

33. MacDonald AA, Herbison GP, et al. The impact of body mass index on semen parameters and reproductive hormones in human males: a systematic review with meta analysis. Hum Reprod Update 2010;16:293–311. DOI: 10.1093/humupd/dmp047.

34. Belanger C, Luu-The V, et al. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm Metab Res 2002;34:737–745. DOI: 10.1055/s-2002-38265.

35. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833–836. DOI: 10.1210/er.2004-0013.

36. Isidori AM, Caprio M, et al. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999;84:3673–3680. DOI: 10.1210/jc.84.10.3673.

37. Aggerholm AS, Thulstrup AM, et al. Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile? Fertil Steril 2008;90:619–626. DOI: 10.1016/j.fertnstert.2007.07.1292.

38. Qin DD, Yuan W, et al. Do reproductive hormones explain the association between body mass index and semen quality? Asian J Androl 2007;9:827–834. DOI: 10.1111/j.1745-7262.2007.00268.x.

39. Stanik S, Dornfeld LP, et al. The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab 1981;53:828–832. DOI: 10.1210/jcem-53-4-828.

40. Strain GW, Zumoff B, et al. Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men. J Clin Endocrinol Metab 1988;66:1019–1023. DOI: 10.1210/jcem-66-5-1019.

41. Pasquali R, Casimirri F, et al. Weight loss and sex steroid metabolism in massively obese man. J Endocrinol Invest 1988;11:205–210. DOI: 10.1007/BF03350136.

42. Bastounis EA, Karayiannakis AJ, et al. Sex hormone changes in morbidly obese patients after vertical banded gastroplasty. Eur Surg Res 1998;30:43–47. DOI: 10.1159/000008556.

43. Kaukua J, Pekkarinen T, et al. Sex hormones and sexual function in obese men losing weight. Obes Res 2003;11:689–694. DOI: 10.1038/oby.2003.98.

44. Niskanen L, Laaksonen DE, et al. Changes in sex hormone binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 2004;6:208–215. DOI: 10.1111/j.1462-8902.2004.00335.x.

45. Makler A, Zaidise I, et al. Elimination of errors induced during a routine human sperm motility analysis. Arch Androl 1979;3:201–210. DOI: 10.3109/01485017908988406.

46. Rosner B. Fundamentals of Biostatistics, Duxbury; 2000. pp. 80–240.

47. Riffenburg RH. Statistics in Medicine, Academic press; 2005. pp. 85–125.

48. Sunder Rao PSS, Richard J. An Introduction to Biostatistics, A manual for students in health sciences. New Delhi: Prentice hall of India, 2006. pp. 86–160.

49. Suresh KP, Chandrasekhar S. Sample Size estimation and Power analysis for Clinical research studies. J Hum Reprod Sci 2012;5(1):7–13. DOI: 10.4103/0974-1208.97779.

50. Jensen TK, Andersson AM, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004;82:863–870. DOI: 10.1016/j.fertnstert.2004.03.056.

51. Koloszar S, Daru J, et al. Effect of female body weight on efficiency of donor AI. Arch Androl 2002;48:323–327. DOI: 10.1080/01485010290099156.

52. Kort HI, Massey JB, et al. Impact of body mass index values on sperm quantity and quality. J Androl 2006;27:450–452. DOI: 10.2164/jandrol.05124.

53. Sallmen M, Sandler DP, et al. Reduced fertility among overweight and obese men. Epidemiol 2006;17:520–523. DOI: 10.1097/01.ede.0000229953.76862.e5.

54. Nguyen R, Wilcox A, et al. Men’s body mass index and infertility. Hum Reprod 2007;22:2488–2493. DOI: 10.1093/humrep/dem139.

55. Semple PA, Graham A, et al. Hypoxia, depression of testosterone, and impotence in pickwickian syndrome reversed by weight reduction. Br Med J (Clin Res Ed) 1984;289:801–802. DOI: 10.1136/bmj.289.6448.801.

56. Hannan JL, Maio MT, et al. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. J Sex Med 2009;6(Suppl 3):254–261. DOI: 10.1111/j.1743-6109.2008.01143.x.

57. Hammoud A, Gibson M, et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab 2009;94:1329–1332. DOI: 10.1210/jc.2008-1598.

58. di Frega AS, Dale B, et al. Secondary male factor infertility after Roux-en-Y gastric bypass for morbid obesity: case report. Hum Reprod 2005;20:997–998. DOI: 10.1093/humrep/deh707.

________________________
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.